Delivery Order SPE2DR25D6029-SPE2DR26FXQ0S
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on May 2, 2025, for the supply of Venclexta 100 mg tablets (120 count) at a ceiling value of $9,728.17. This is a firm fixed-price delivery order with no set-aside designation, representing a competitively awarded contract. The order is set for ultimate completion by May 23, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued...
- The Defense Logistics Agency awarded a $20,503.98 delivery order to AmerisourceBergen Drug Corp for the supply of Venclexta 100 mg tablets (120 count) on November 4, 2025, with completion scheduled for November 26, 2025. This competitively awarded, firm fixed-price contract is classified as a non-set-aside procurement and represents a child order under AmerisourceBergen's larger pharmaceutical supply vehicle with DLA. The product will be delivered to the company's corporate office location in...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 21, 2025, for the supply of Venclexta 100 mg tablets in a quantity of 120 units, with a contract ceiling value of $20,503.98. This competitively awarded, firm fixed-price delivery order is scheduled for completion by November 12, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a non-set-aside procurement, reflecting...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for Venclexta 100 mg tablets in a quantity of 120 units, valued at $9,728.17. This competitively awarded, firm fixed-price delivery order, issued on October 27, 2025, will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of November 18, 2025. The contract carries no set-aside designation, reflecting the open competition...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 29, 2025, for the supply of Venclexta 100 mg tablets (120 count) valued at $9,728.17. This competitively awarded, firm fixed-price delivery order is set to conclude by October 21, 2025, and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $38,912.68 to AmerisourceBergen Drug Corp for the supply of Venclexta 100 mg tablets (120-count units) with a completion date of July 22, 2025. This firm fixed-price, competitively awarded delivery order leverages AmerisourceBergen's broader pharmaceutical supply relationship with the federal government and represents a non-set-aside procurement. The contract was awarded on June 30, 2025, with performance conducted at the...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $19,456.34 to AmerisourceBergen Drug Corp for the supply of Venclexta 100 mg tablets (120-count units). This firm fixed-price, competitively awarded contract with no set-aside designation is scheduled for completion by October 6, 2025, and represents a delivery order under the company's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The place of performance is AmerisourceBergen's corporate office...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 23, 2025, for the supply of Venclexta 100 mg tablets (120-count units) valued at $9,728.17, with completion scheduled for October 15, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $19,456.34 to AmerisourceBergen Drug Corp for supply of Venclexta 100 mg tablets (120-count units) on September 22, 2025, with completion targeted for October 14, 2025. This is a firm fixed-price, competitively awarded contract with no set-aside designation. The order will be fulfilled from the vendor's Conshohocken, Pennsylvania location, where AmerisourceBergen maintains its corporate headquarters as a major pharmaceutical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 25, 2025, for the supply of Venclexta 100 mg tablets (120-count units) with a contract ceiling value of $9,728.17. This is a firm fixed-price delivery order with an ultimate completion date of August 15, 2025, and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The...
- SPE2DR25D6029Indefinite Delivery Contract
- SPE2DR25D6029-SPE2DR26FXQ0SDelivery Order
The Defense Logistics Agency has awarded a $20,503.98 delivery order to AmerisourceBergen Drug Corp for the supply of Venclexta 100 mg tablets (120 count units) with a completion date of December 4, 2025. This is a firm fixed-price, competitively awarded contract with no set-aside designation. The award was issued on November 12, 2025, and AmerisourceBergen will perform the delivery from its corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. This master contract serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply a broad range of medications, vaccines, medical devices, and specialized healthcare commodities to support military healthcare programs and other federal healthcare systems, including the Defense Health Agency and U.S. Coast Guard. Venclexta, a specialty oncology medication, represents one of the critical pharmaceutical products available through this strategic contract vehicle that supports federal medical procurement requirements across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $20.5k | 11/12/25 |